Screening for impaired fasting glucose and diabetes using available health plan data
- 12 April 2013
- journal article
- Published by Elsevier BV in Journal of Diabetes and its Complications
- Vol. 27 (6), 580-587
- https://doi.org/10.1016/j.jdiacomp.2013.01.003
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- The 10-Year Cost-Effectiveness of Lifestyle Intervention or Metformin for Diabetes PreventionDiabetes Care, 2012
- Estimating the Risk of Developing Type 2 Diabetes: A Comparison of Several Risk ScoresDiabetes Care, 2011
- Diagnosis and Classification of Diabetes MellitusDiabetes Care, 2011
- Pre-Diabetes and the Risk for Cardiovascular Disease: A Systematic Review of the EvidenceJournal of the American College of Cardiology, 2010
- Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trialThe Lancet, 2006
- A multivariate logistic regression equation to screen for dysglycaemia: development and validationDiabetic Medicine, 2005
- Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trialThe Lancet, 2002
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminThe New England Journal of Medicine, 2002
- Prevention of Type 2 Diabetes Mellitus by Changes in Lifestyle among Subjects with Impaired Glucose ToleranceThe New England Journal of Medicine, 2001
- Relation of Impaired Fasting and Postload Glucose With Incident Type 2 Diabetes in a Dutch PopulationJAMA, 2001